Hua Medicine (Shanghai) Ltd.

HUMDF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$250-$211-$204-$326
Dep. & Amort.$35$36$32$32
Deferred Tax$0$0$0$10
Stock-Based Comp.$12$24$21$33
Change in WC-$108$1,131-$27-$19
Other Non-Cash-$106-$91-$53-$2
Operating Cash Flow-$418$889-$230-$273
Investing Activities
PP&E Inv.-$3-$10-$27-$67
Net Acquisitions$0$0-$1$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$13$18$23-$1
Investing Cash Flow$10$8-$5-$68
Financing Activities
Debt Repay.$113$90$11-$16
Stock Issued$2$10$11$10
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$31-$31-$0$0
Financing Cash Flow$84$69$21-$6
Forex Effect$3$4$29-$10
Net Chg. in Cash-$321$970-$185-$357
Supplemental Information
Beg. Cash$1,461$491$675$1,032
End Cash$1,140$1,461$491$675
Free Cash Flow-$422$880-$258-$340
Hua Medicine (Shanghai) Ltd. (HUMDF) Financial Statements & Key Stats | AlphaPilot